Anionic pulmonary surfactant lipid regulation of innate immunity

Expert Review of Respiratory Medicine

Volumn 6, Issue 3, 2012, Pages 243-246

  Numata, Mari ^a   Kandasamy, Pitchaimani ^a   Voelker, Dennis R ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

acute lung injury; acute respiratory distress; antivirals; asthma; chronic obstructive pulmonary disease; influenza A virus; respiratory syncytial virus; Toll like receptors

Indexed keywords

CD14 ANTIGEN; LIPID; LIPOPOLYSACCHARIDE; LUNG SURFACTANT; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; PALMITOYL OLEOYL PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLGLYCEROL; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ATTENUATION; CHEMICAL INTERACTION; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MYCOPLASMA FERMENTANS; MYCOPLASMA PNEUMONIAE; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; VACCINATION;

EID: 84863976168     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.12.21     Document Type: Review

References (31)

1. Wright JR. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5(1), 58-68 (2005
2. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147(1), 218-233 (1993
3. Nieman GF, Bredenberg CE, Clark WR, West NR. Alveolar function following surfactant deactivation. J. Appl. Physiol. 51(4), 895-904 (1981
4. Enhorning G, Holm BA. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J. Appl. Physiol. 74(6), 2922-2927 (1993
5. Schmidt R, Meier U, Markart P et al. Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease. Am. J. Physiol. Lung Cell Mol. Physiol. 283(5), L1079-L1085 (2002
6. Wright SM, Hockey PM, Enhorning G et al. Altered airway surfactant phospholipid composition and reduced lung function in asthma. J. Appl. Physiol. 89(4), 1283-1292 (2000
7. Zuo YY, Veldhuizen RA, Neumann AW, Petersen NO, Possmayer F. Current perspectives in pulmonary surfactant - inhibition, enhancement and evaluation. Biochim. Biophys. Acta 1778(10), 1947-1977 (2008
8. Numata M, Voelker DR. Sutherland ER Asthma and infections. In: LUNG Biology in Health and Disease. Martin RJ, (Eds). Informa Healthcare, NY, USA, 45-165 (2010
9. Kuronuma K, Mitsuzawa H, Takeda K et al. Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-Interacting proteins CD14 and MD-2. J. Biol. Chem. 284(38), 25488-25500 (2009
10. Kandasamy P, Zarini S, Chan ED, Leslie CC, Murphy RC, Voelker DR. Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-Stimulated eicosanoid production from human and mouse macrophages. J. Biol. Chem. 286(10), 7841-7853 (2011
11. Mueller M, Brandenburg K, Dedrick R, Schromm AB, Seydel U. Phospholipids inhibit lipopolysaccharide (LPS)-Induced cell activation: A role for LPS-Binding protein. J. Immunol. 174(2), 1091-1096 (2005
12. Hashimoto M, Asai Y, Ogawa T. Treponemal phospholipids inhibit innate immune responses induced by pathogen-Associated molecular patterns. J. Biol. Chem. 278(45), 44205-44213 (2003
13. Numata M, Chu HW, Dakhama A, Voelker DR. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-Induced inflammation and infection. Proc. Natl Acad. Sci. USA 107(1), 320-325 (2010
14. Numata M, Kandasamy P, Nagashima Y et al. Phosphatidylglycerol suppresses influenza A virus infection. Am. J. Respir. Cell Mol. Biol. 46, 479-487 (2012
15. Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care 7(1), 1-7 (2001
16. Ware LB, Matthay MA. The acute respiratory distress syndrome. N. Engl. J. Med. 342(18), 1334-1349 (2000
17. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169(1), 333-338 (1989
18. Kline JN, Cowden JD, Hunninghake GW et al. Variable airway responsiveness to inhaled lipopolysaccharide. Am. J. Respir. Crit. Care Med. 160(1), 297-303 (1999
19. Nagai Y, Akashi S, Nagafuku M et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3(7), 667-672 (2002
20. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282(5396), 2085-2088 (1998
21. Savov JD, Gavett SH, Brass DM, Costa DL, Schwartz DA. Neutrophils play a critical role in development of LPS-Induced airway disease. Am. J. Physiol. Lung Cell Mol. Physiol. 283(5), L952-L962 (2002
22. Akira S, Takeda K. Toll-Like receptor signalling. Nat. Rev. Immunol. 4(7), 499-511 (2004
23. Shimizu T, Kida Y, Kuwano K. A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-Kappa B through TLR1, TLR2, and TLR6. J. Immunol. 175(7), 4641-4646 (2005
24. Seya T, Matsumoto M. A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-Like receptor 2. Int. J. Biochem. Cell Biol. 34(8), 901-906 (2002
25. Aliprantis AO, Yang RB, Mark MR et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-Like receptor-2. Science 285(5428), 736-739 (1999
26. Ozinsky A, Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-Like receptors. Proc. Natl Acad. Sci. USA 97(25), 13766-13771 (2000
27. Kurt-Jones EA, Popova L, Kwinn L et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1(5), 398-401 (2000
28. Hall CB. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344(25), 1917-1928 (2001
29. MacDowell AL, Bacharier LB. Infectious triggers of asthma. Immunol. Allergy Clin. North Am. 25(1), 45-66 (2005
30. Wedzicka JA. Exacerbations: Etiology and pathophysiologic mechanisms. Chest 121(5), S136-S141 (2002
31. Glezen WP. Clinical practice. Prevention and treatment of seasonal influenza. N. Engl. J. Med. 359(24), 2579-2585 (2008)